Receptor for advanced glycation end products and neuronal deficit in the fatal brain edema of diabetic ketoacidosis

Brain Research

Volumn 1238, Issue , 2008, Pages 154-162

  Hoffman, William H ^a   Artlett, Carol M ^b   Zhang, Weixian ^c   Kreipke, Christian W ^c   Passmore, Gregory G ^a   Rafols, Jose A ^c   Sima, Anders A F ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocytosis; Diabetic encephalopathy; Diabetic ketoacidosis; Neuroinflammation; Neuronal deficit; White matter atrophy

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADOLESCENT; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN ATROPHY; BRAIN BLOOD VESSEL; BRAIN EDEMA; CASE REPORT; CHOROID PLEXUS; DIABETIC KETOACIDOSIS; FATALITY; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; NERVE CELL; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE MATTER;

ADOLESCENT; BRAIN EDEMA; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; NEURONS; RECEPTORS, IMMUNOLOGIC;

ANIMALIA; RATTUS;

EID: 55349091659     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.08.041     Document Type: Article

References (69)

1. Aguilar-Hernandeza M., and Mendez J.D. In vitro glycation of brain aminophospholipids by acetoacetate and its inhibition by urea Biomed. Pharmacother. 61 2007 383 391
2. Anitha M., Gondha C., Sutliff R., Parsadanian A., Mwangi S., Sitaraman S.V., and Srinivasan S. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the P13K/Akt pathway J. Clin. Invest. 116 2006 34 356
3. Aragno M., Mastrocola R., Medana C., Restivo F., Catalano M.G., Pons N., Danni O., and Boccuzzi G. Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment Endocrinology 146 2005 5561 5567
4. Araque A., Parpura V., Sanzgiri R.P., and Haydon P.G. Glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons Eur. J. Neurosci. 10 1998 2129 2142
5. Arvanitakis Z., Wilson R.S., Bienias J.L., Evans D.A., and Bennett D.A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function Arch. Neurol. 61 2004 661 666
6. Baynes J.W., and Thorpe S.R. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm Diabetes 48 1999 1 9
7. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., and Volterra A. CXCR4-activated astrocyte glutamate release via TNF alpha: amplification by microglia triggers neurotoxicity Nat. Neurosci. 4 2001 702 710
8. Bopp C., Bierhaus A., Hofer S., Bouchon A., Nawroth P.P., Martin E., and Weigand M.A. Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis Crit. Care 12 2008 201
9. Ceriello A. Oxidative stress and diabetes-associated complications Endocr. Pract. 12 Suppl. 1 2006 60 62
10. Crossgrove J.S., Li G.J., and Zheng W. The choroid plexus removes beta-amyloid from brain cerebrospinal fluid Exp. Biol. Med. 230 2005 771 7716
11. Couch R.M., Acott P.D., and Wong G.W. Early onset fatal cerebral edema in diabetic ketoacidosis Diabetes Care 14 1991 78 79
12. Dalton R.R., Hoffman W.H., Passmore G.G., and Martin S.L. Plasma C-reactive protein levels in severe diabetic ketoacidosis Ann. Clin. Lab. Sci. 33 2003 435 442
13. Dillon E.S., Riggs H.E., and Dyer W.W. Cerebral lesions in uncomplicated fatal diabetic acidosis Am. J. Med. Sci. 192 1936 360 365
14. Donahue J.E., Flaherty S.L., Johanson C.E., Duncan J.A. III, Silverberg G.D., Miller M.C., Tavares R., Yang W., Wu Q., Sabo E., Hovanesian V., and Stopa E.G. RAGE, LRP-1 and amyloid-beta protein in Alzheimer's disease Acta Neuropathol. 112 2006 405 415
15. Downen M., Amaral T.D., Hua L.L., Zhao M.L., and Lee S.C. Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-alpha Glia 28 1999 114 127
16. Dunlop K.A., Woodman D., and Carson D.J. Hypopituitarism following cerebral oedema with diabetic ketoacidosis Arch. Dis. Child. 87 2002 337 338
17. Edge J.A., Hawkins M.M., Winter D.L., and Dunger D.B. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis Arch. Dis. Child. 85 2001 16 22
18. Farina C., Aloisi F., and Meini E. Astrocytes are active players in cerebral innate immunity Trends Immunol. 28 2007 138 145
19. Ferguson S.C., Blane A., Perros P., McCrimmon R.J., Best J.J., Wardlaw J., Deary I.J., and Frier B.M. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceeding severe hypoglycemia Diabetes 52 2003 149 156
20. Frank R.N., Hoffman W.H., Podgor M.J., Joondeph H.C., Lewis R.A., Margherio R.R., Nachazel D.P. Jr., Weiss H., Christopherson K.W., and Cronin M.A. Retinopathy in juvenile-onset type 1 diabetes of short duration Diabetes 31 1982 874 882
21. Goh S.Y., and Cooper M.E. Review: The role of advanced glycation end products in progression and complications of diabetes J. Clin. Endocrinol. Metab. 93 2008 1143 1152
22. Hoffman W.H., Kappler F., Passmore G.G., and Mehta R. Diabetic ketoacidosis and its treatment increase plasma 3-deoxyglucosone Clin. Biochem. 36 2003 269 273
23. Hoffman W.H., Burek C.L., Waller J.L., Fisher L.E., Khichi M., and Mellick L.B. Cytokine response to diabetic ketoacidosis and its treatment Clin. Immunol. 108 2003 175 181
24. Hoffman W.H., Cudrici C.D., Zafranskaia E., and Rus H. Complement activation in diabetic ketoacidosis brains Exp. and Mol. Pathol. 80 2006 283 288
25. Hoffman W.H., Casanova M.F., Cudrici C.D., Zakranskaia E., Venugopalan R., Nag S., Oglesbee M.J., and Rus H. Neuroinflammatory response of the choroid plexus epithelium in fatal diabetic ketoacidosis Exp. and Mol. Pathol. 83 2007 65 72
26. Hood K.K., Huestis S., Maher A., Butler D., Volkening L., and Laffel L.M.B. Depressive symptoms in children and adolescents with type 1 diabetes Diabetes Care 29 2006 1389 1391
27. Isgaard J., Aberg D., and Nilsson M. Protective and regenerative effects of the GH/IGH-1 axis on the brain Minerva Endocrinol. 32 2007 103 113
28. Jain S.K., McVie R., and Bocchini J.A. Jr. Hyperketonemia (ketosis), oxidative stress and type 1 diabetes Pathophysiology 13 2006 163 170
29. Jerath R.S., Burek C.L., Hoffman W.H., and Passmore G.G. Complement activation in diabetic ketoacidosis and its treatment Clin. Immunol. 116 2005 11 17
30. Jono T., Nagal R., Lin X., Ahmed N., Thornalley P.J., Takeya M., and Horiuchi S. Nepsilon-(Carboxymethyl)lysine and 3-DG-imidazolone are major AGE structures in protein modification by 3-deoxyglucosone J. Biochem. 136 2004 351 358
31. Kashiwaya Y., Takeshima T., Mori N., Nakashima K., Clarke K., and Veech R.L. d-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease Proc. Natl. Acad. Sci. 97 2000 5440 5444
32. Kikuchi S., Shinpo K., Moriwaka F., Makita Z., Miyata T., and Tashiro K. Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases J. Neurosci. Res. 57 1999 280 289
33. Lau L.T., and Yu A.C. Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury J Neurotrauma 18 2001 351 359
34. Lazovic J., Basu A., Lin H.W., Rothstein R.P., Krady J.K., Smith M.B., and Levison S.W. Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection Stroke 36 2005 2226 2231
35. Lee D.M., Hoffman W.H., Carl G.F., Mahmood K., and Cornwell P.E. Lipid peroxidation and antioxidant vitamins prior to, during, and after correction of diabetic ketoacidosis J. Diabetes Complications 16 2002 294 300
36. Leonard B.E. Inflammation, depression, and dementia: are they connected? Neurochem Res. 32 2007 1749 1756
37. Li Z.-G., Zhang W., Grunberg G., and Sima A.A.F. Hippocampal neuronal apoptosis in type 1 diabetes Brain Res. 946 2002 221 231
38. Li Z.-G., Zhang W., and Sima A.A.F. Alzheimer-like changes in rat models of spontaneous diabetes Diabetes 56 2007 1817 1824
39. Liliensiek B., Weigand M.A., Bierhaus A., Nicklas W., Kasper M., Hofer S., Plachky J., Grone H.J., Kurschus F.C., Schmidt A.M., Yan S.D., Martin E., Schleicher E., Stern D.M., Hammerling G.G., Nawroth P.P., and Arnold B. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J. Clin. Invest. 113 2004 1641 1650
40. Lobnig B.M., Kroemeke O., Optenhostert-Porst C., and Wolf O.T. Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications Diabet. Med. 23 2006 32 39
41. Lue L.F., Walker D.G., Brachova L., Beach T.G., Rogers J., Schmidt A.M., Stern D.M., and Yan S.D. Involvement of microglia receptor for advanced glycation end products (RAGE) in Alzheimer's disease: Identification of a cellular activation mechanism Exp. Neurol. 171 2001 29 45
42. Mukherjee T.K., Mukhopadhyay S., and Hoidal J.R. The role of reactive oxygen species in TNF alpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells Biochim Biophys Acta 1744 2005 213 223
43. Munoz M.T., Barrios V., Pozo J., and Argente J. Insulin-like growth factor 1, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications Pediatr. Res. 39 1996 992 998
44. Ryan C., Vega A., and Drash A. Cognitive deficits in adolescents who developed diabetes early in life Pediatrics 75 1985 921 927
45. Schmidt A.M., Hofmann M., Taguchi A., Yan S.D., and Stern D.M. RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation Semin. Thromb. Hemost. 26 2000 485 493
46. Shaftel S.S., Kyrkanides S., Olschowka J.A., Miller J.N., Johnson R.E., and O'Banion M.K. Sustained hippocampal IL-1beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology J. Clin. Invest. 117 2007 1483 1485
47. Sima A.A. Acetyl-carnitine in diabetic polyneuropathy: experimental and clinical data CNS Drugs 21 Suppl. 1 2007 13 23
48. Sima A.A.F., and Li Z.G. The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type I diabetic rats Diabetes 54 2005 1497 1505
49. Sima A.A., Zhang W., Xu G., Sugimoto K., Guberski D., and Yorek M.A. A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats Diabetologia 43 2000 786 793
50. Skaper S.D., Facci L., and Leon A. Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induce neuronal degeneration via the nitridergic pathway J. Neurochem. 64 1995 266 276
51. Stahel P.F., Morganti-Kossmann M.C., Perez D., Redaelli C., Gloor B., Trentz O., and Kossmann T. Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury J Neurotrauma 18 2001 773 781
52. Takeuchi M., Bucala R., Suzuki T., Ohkubo T., Yamazaki M., Koike T., Kameda Y., and Makita Z. Neurotoxicity of advanced glycation end-products for cultured cortical neurons J. Neuropathol. Exp. Neurol. 59 2000 1094 1105
53. Tesfaye S., Stevens L.K., Stephenson J.M., Fuller J.H., Plater M., Ionescu-Tirgoviste C., Nuber A., Pozza G., and Ward J.D. Prevalence of diabetic peripheral neuropathy and its relation to glycemic control and potential risk factors: the EURODIAB IDDM Complications Study Diabetologia 39 1996 1377 1384
54. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N. Engl. J. Med. 329 1993 977 986
55. Thornalley P.J., Langborg A., and Minhas H.S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose Biochem. J. 344, Pt 1 1999 109 116
56. Tichauer J., Saud K., and von Bernhardi R. Modulation by astrocytes of microglia cell-mediated neuroinflammation: effect on the activation of microglia signaling pathways Neuroimmunomodulation 14 2007 168 174
57. Toth C., Schmidt A.M., Tuor U.I., Francis G., Foniok T., Brussee V., Kaur J., Yan S.F., Martinez J.A., Barber P.A., Buchan A., and Zochodne D.W. Diabetes, leukoencephalopathy and rage Neurobiol. Disease 23 2006 445 461
58. Toth C., Rong L.L., Yang C., Martinez J., Song F., Ramji N., Brussee V., Liu W., Durand J., Nguyen M.D., Schmidt A.M., and Zochodne D.W. Receptor for Advanced Glycation End Products (RAGEs) and experimental diabetic neuropathy Diabetes 57 2008 1002 1017
59. Troy P.J., Clark R.P., Kakarala S.G., Burns J., Silverman I.E., and Shore E. Cerebral edema during treatment of diabetic ketoacidosis in an adult with new onset diabetes Neurocrit. Care 2 2005 55 58
60. Turk Z., Nemet I., Varga-Defteardarovic L., and Car N. Elevated level of methylglyoxal during diabetic ketoacidosis and its recovery phase Diabetes Metab. 32 2006 176 180
61. Vance J.E. Glycerolipids. Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically-related aminophospholipids J. Lipid Res. 49 2008 1377 1387
62. Venters H.D., Dantzer R., and Kelley K.W. Tumor necrosis factor-alpha induces neuronal death by silencing survival signals generated by the type 1 insulin-like growth factor receptor Ann. N. Y. Acad. Sci. 917 2000 210 220
63. Wang Z., Li D.D., Liang Y.Y., Wang D.S., and Cai N.S. Activation of astrocytes by advanced glycation end products: cytokines induction and nitric oxide release Acta Pharmacol. Sin. 23 2002 974 980
64. Warren P., Villaluz E.S., and Rosenberg H. Diabetic ketoacidosis with fatal cerebral edema Pediatrics 43 1969 620 622
65. Wautier J.L., and Schmidt A.M. Protein glycation: a firm link to endothelial cell dysfunction Circ. Res. 95 2004 233 238
66. Wessels A.M., Rombouts A.R.B., Remijnse P.L., Boom Y., Scheltens P., Barkhof F., Heine R.J., and Snock F.J. Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume Diabetologia 50 2007 1763 1769
67. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., Pinsky D., and Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins J. Biol. Chem. 269 1994 9889 9897
68. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A.M. RAGE and amyloid-í peptide neurotoxicity in Alzheimer's disease Nature 382 1996 685 691
69. Zhong Y., Li S.H., Liu S.M., Szmitko P.E., He X.Q., Fedak P.W., and Verma S. C-reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells Hypertension 48 2006 504 511